Sector: Health Care
Director information for AMGEN INC (data for year 2026)
| Name | Position | Age | Qualifications and Experience | Committee Memberships | Filing Year |
|---|---|---|---|---|---|
| Amy E. Miles | Director | 59 | ["Chief Executive Officer and Director of Regal Entertainment Group","Chair of the Board of Regal Entertainment","Executive Vice President, Chief Financial Officer and Treasurer of Regal Entertainment","Chief Executive Officer of Regal Cinemas","Director of The Gap, Inc.","Director of Carrier Global Corporation","Director of Norfolk Southern Corporation","Director of National CineMedia, Inc.","Director of Townsquare Media, Inc.","Board of Trustees of the Boys and Girls Club of the Tennessee Valley","Extensive finance, accounting, and management expertise","Audit Committee financial expert","Audit Committee financial expert under The NASDAQ Stock Market listing standards and the requirements of the SEC"] | ["Compensation and Management Development","M","Audit","Governance and Nominating","Audit Committee"] | 2026 |
| Brian J. Druker | Director | 70 | ["President of Oregon Health & Science University","Physician-scientist","Professor of medicine","JELD-WEN chair of leukemia research","Former associate dean for oncology of the OHSU School of Medicine","Former investigator with the Howard Hughes Medical Institute","Former director of Vincerx Pharma, Inc.","Member of the scientific advisory board of Aptose Biosciences Inc.","Founder of Blueprint Medicines Corporation","Founder of MolecularMD","Member of the board of directors of the Burroughs Wellcome Fund","Lasker-DeBakey Clinical Research Award recipient","Japan Prize in Healthcare and Medical Technology recipient","Albany Medical Center Prize recipient","Sjöberg Prize recipient","Elected to the National Academy of Sciences","Elected to the National Academy of Medicine","Undergraduate degree and medical doctorate from University of California, San Diego"] | ["Compensation and Management Development","M","Corporate Responsibility and Compliance","Corporate Responsibility and Compliance Committee"] | 2026 |
| Charles M. Holley, Jr. | Director; Chair | 69 | ["former Executive Vice President and Chief Financial Officer for Walmart Inc.","Audit Committee financial expert","various roles in Walmart International","over ten years with Ernst & Young LLP","Independent Senior Advisor, U.S. CFO Program, at Deloitte LLP","Audit Committee financial expert under The NASDAQ Stock Market listing standards and the requirements of the SEC"] | ["Audit","Governance and Nominating","Compensation and Management Development","C","M","Executive","Audit Committee"] | 2026 |
| Ellen J. Kullman | Director; Chair | 70 | ["Chair of the Board at Carbon, Inc.","Former President and CEO of Carbon, Inc.","Former President, Chair and CEO of DuPont","Experience as a board member of Goldman Sachs Group, Inc.","Experience as a board member of Dell Technologies Inc.","Former director of United Technologies Corporation","Former director of General Motors","Bachelor of Science in Mechanical Engineering from Tufts University","Master’s degree from Kellogg School of Management at Northwestern University"] | ["Compensation and Management Development","M","C","Corporate Responsibility and Compliance","Governance and Nominating","Corporate Responsibility and Compliance Committee"] | 2026 |
| Greg C. Garland | Director | 68 | ["Executive chairman of Phillips 66","Chairman and CEO of Phillips 66","Senior VP of Exploration and Production at ConocoPhillips","President and CEO of Chevron Phillips Chemical Company","Various positions at Phillips Petroleum Company","Undergraduate degree in Chemical Engineering from Texas A&M University","Member of the Engineering Advisory Council for Texas A&M University","Member of the board of visitors at The University of Texas MD Anderson Cancer Center","Vice chairman of the Barbara Bush Literacy Foundation","Experience as chief executive officer and chairman","Expertise in financial reporting, risk management, environmental issues, business transformations and capital markets","Significant experience with public policy and government affairs"] | ["Audit","Governance and Nominating","Compensation and Management Development","C","M","Executive"] | 2026 |
| Mary E. Klotman | Director | 72 | ["Executive Vice President for Health Affairs of Duke University since 2023","Dean of the Duke University School of Medicine since 2017","Chief Academic Officer of Duke Health since 2020","Chair of the Department of Medicine at Duke University School of Medicine from 2010 to 2017","Irene and Dr. Arthur M. Fishberg Professor of Medicine at Mount Sinai School of Medicine","Chief of Division of Infectious Diseases at Mount Sinai from 1997 to 2010","Co-director of Mount Sinai’s Global Health and Emerging Pathogens Institute","Director of Inventurus Knowledge Solutions Limited since 2024","Advisory board member of Inventurus Knowledge Solutions Limited since 2022","Elected to the National Academy of Medicine in 2014","Elected to the American Academy of Arts and Sciences in 2021","Received undergraduate degree and medical doctorate from Duke University"] | ["Compensation and Management Development","M","Corporate Responsibility and Compliance","Governance and Nominating","Corporate Responsibility and Compliance Committee"] | 2026 |
| Michael V. Drake | Director | 75 | ["Retired President of the University of California","Distinguished Professor of Ophthalmology at UCSF","Former President of The Ohio State University","Chancellor and Distinguished Professor at UC Irvine","Vice President for Health Affairs for the University of California system","Faculty at UCSF School of Medicine since 1979"] | ["Compensation and Management Development","M","Corporate Responsibility and Compliance","Governance and Nominating","Corporate Responsibility and Compliance Committee"] | 2026 |
| Robert A. Bradway | Chairman of the Board; Chief Executive Officer and President | 63 | ["President since 2010","Chief Executive Officer since 2012","Former Chief Operating Officer from 2010 to 2012","Former Vice President, Operations Strategy at Amgen","Former Managing Director at Morgan Stanley in London","Director of The Boeing Company since 2016","Board of trustees of USC since 2014","Bachelor’s degree in biology from Amherst College","Master’s degree in business administration from Harvard Business School"] | ["Compensation and Management Development","C","M","Equity Award","Executive"] | 2026 |
| Robert A. Eckert | Lead Independent Director | 71 | ["Operating Partner at FFL Partners, LLC","Chief Executive Officer of Mattel, Inc.","President and Chief Executive Officer of Kraft Foods Inc.","Director of Levi Strauss & Co.","Director of Uber Technologies, Inc.","Director of McDonald’s Corporation","Director of Eyemart Express Holdings LLC","Eller College national board of advisors at the University of Arizona","global advisory board of the Kellogg School of Management","Active Experienced Lead Independent Director","Robust Responsibilities","Sound and robust oversight of management"] | ["Compensation and Management Development(Chair)","Executive","Governance and Nominating","Audit","Compensation and Management Development","M","C"] | 2026 |
| S. Omar Ishrak | Director | 70 | ["former executive chairman and chairman of the board of Medtronic plc","chief executive officer of Medtronic","President and Chief Executive Officer of GE Healthcare Systems","experience as chairman of the board of Intel Corporation","senior advisor to Blackstone Life Sciences","inducted into the American Institute for Medical and Biological Engineering College of Fellows","fellow of King’s College London","inducted into the Bakken Society","elected to the National Academy of Engineering"] | ["Compensation and Management Development","M","Audit","Nominating and Corporate Governance Committee","Audit Committee"] | 2026 |
| Tyler Jacks | Director | 65 | ["David H. Koch Professor of Biology at MIT","Founding director of the David H. Koch Institute for Integrative Cancer Research","President and director of Break Through Cancer","Investigator with the Howard Hughes Medical Institute","Director of Thermo Fisher Scientific, Inc.","Chair of the Science and Technology Committee at Thermo Fisher Scientific, Inc.","Co-founder of T2 Biosystems, Inc.","Chair of the scientific advisory board at Dragonfly Therapeutics, Inc.","Served on the Harvard University Board of Overseers","Member of the National Cancer Advisory Board","Scientific advisory roles in various biotechnology companies","Recipient of multiple awards for contributions to cancer research","Elected to the National Academy of Sciences and the National Academy of Medicine"] | ["Compensation and Management Development","M","Corporate Responsibility and Compliance","Corporate Responsibility and Compliance Committee"] | 2026 |
| Wanda M. Austin | Director | 71 | ["Retired President and Chief Executive Officer of The Aerospace Corporation","Senior Vice President, National Systems Group of The Aerospace Corporation","Interim President of the University of Southern California","Adjunct Research Professor at USC’s Viterbi School of Engineering","Co-founder of MakingSpace, Inc.","Director of Apple Inc. since 2024","Director of Chevron Corporation since 2016 and lead independent director since 2022","Life trustee of USC","Served on boards of directors of the National Geographic Society and the Space Foundation","Undergraduate degree from Franklin & Marshall College","Master’s degree from the University of Pittsburgh","Doctorate from USC","Member of the National Academy of Engineering","Leadership and management experience as a chief executive officer","Extensive background in science, technology, and government affairs in a highly regulated industry"] | ["Audit","M","Compensation and Management Development","Audit Committee"] | 2026 |
